These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6149907)

  • 21. Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
    Cone EJ; Darwin WD; Buchwald WF; Gorodetzky CW
    Drug Metab Dispos; 1983; 11(5):446-50. PubMed ID: 6194952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine.
    Filitz J; Griessinger N; Sittl R; Likar R; Schüttler J; Koppert W
    Eur J Pain; 2006 Nov; 10(8):743-8. PubMed ID: 16426877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats.
    Yassen A; Kan J; Olofsen E; Suidgeest E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2007 May; 321(2):598-607. PubMed ID: 17283225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion and metabolism of 14C-midazolam in humans following oral dosing.
    Heizmann P; Ziegler WH
    Arzneimittelforschung; 1981; 31(12a):2220-3. PubMed ID: 7199324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry.
    Fox EJ; Tetlow VA; Allen KR
    J Anal Toxicol; 2006 May; 30(4):238-44. PubMed ID: 16803661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine: new pharmacological aspects.
    Cowan A
    Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
    Chang Y; Moody DE; McCance-Katz EF
    Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes.
    Mercolini L; Mandrioli R; Conti M; Leonardi C; Gerra G; Raggi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):95-102. PubMed ID: 17046338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma.
    Pirnay S; Hervé F; Bouchonnet S; Perrin B; Baud FJ; Ricordel I
    J Pharm Biomed Anal; 2006 Jun; 41(4):1135-45. PubMed ID: 16554136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole greatly increases the exposure to oral buprenorphine.
    Fihlman M; Hemmilä T; Hagelberg NM; Backman JT; Laitila J; Laine K; Neuvonen PJ; Olkkola KT; Saari TI
    Eur J Clin Pharmacol; 2018 Dec; 74(12):1615-1622. PubMed ID: 30167757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine.
    Wang G; Vincent M; Rodrigues W; Agrawal A; Moore C; Barhate R; Abolencia E; Coulter C; Soares J; Zheng YF; Taylor C; Morjana N
    J Anal Toxicol; 2007 Sep; 31(7):377-82. PubMed ID: 17725885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Buprenorphine abuse in a series of 50 drug addicts hospitalized at a Drug Dependence Evaluation hospital in Marseille].
    Arditti J; Bourdon JH; Jean P; Landi H; Nasset D; Jouglard J; Thirion X
    Therapie; 1992 Nov; 47(6):561-2. PubMed ID: 1301649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of Buprenorphine and Norbuprenorphine in Urine.
    Terrell AR; Adhlakha V; Reddy P
    Methods Mol Biol; 2019; 1872():51-59. PubMed ID: 30350278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
    Mendelson JH; Ellingboe J; Mello NK; Kuehnle J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):252-5. PubMed ID: 7057390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Online solid-phase extraction liquid chromatography-electrospray-tandem mass spectrometry analysis of buprenorphine and three metabolites in human urine.
    Liu AC; Lin TY; Su LW; Fuh MR
    Talanta; 2008 Mar; 75(1):198-204. PubMed ID: 18371868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine.
    Kronstrand R; Nyström I; Andersson M; Gunnarsson L; Hägg S; Josefsson M; Ahlner J
    J Anal Toxicol; 2008 Oct; 32(8):586-93. PubMed ID: 19007507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal intoxication following self-administration of a massive dose of buprenorphine.
    Gaulier JM; Marquet P; Lacassie E; Dupuy JL; Lachatre G
    J Forensic Sci; 2000 Jan; 45(1):226-8. PubMed ID: 10641946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.